• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铁过载通过活性氧物种损害正常造血干/祖细胞,并缩短骨髓增生异常综合征小鼠的存活时间。

Iron overload impairs normal hematopoietic stem and progenitor cells through reactive oxygen species and shortens survival in myelodysplastic syndrome mice.

机构信息

Nankai University School of Medicine, Tianjin, PR China.

Tianjin Children's Hospital, Tianjin, PR China.

出版信息

Haematologica. 2018 Oct;103(10):1627-1634. doi: 10.3324/haematol.2018.193128. Epub 2018 Jun 14.

DOI:10.3324/haematol.2018.193128
PMID:29903757
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6165791/
Abstract

There is increasing clinical evidence to suggest a suppressive effect on hematopoiesis in myelodysplastic syndrome patients with iron overload. However, how iron overload influences hematopoiesis in myelodysplastic syndrome (MDS) remains unknown. Here, the -transduced bone marrow mononuclear cells were yielded and transplanted into lethally irradiated recipient mice together with radioprotective bone marrow cells to generate MDS mice. Eight weeks post transplantation, the recipient mice received an intraperitoneal injection of 0.2 mL iron dextran at a concentration of 25 mg/mL once every other day for a total of 8 times to establish an iron overload model. In the present study, we show that iron overload impairs the frequency and colony-forming capacity of normal hematopoietic stem and progenitor cells, especially in erythroid, in MDS mice, which is due, at least in part, to growth differentiation factor 11-induced reactive oxygen species, shortening survival of MDS mice. Given that we are the first to construct an iron overload model in MDS mice, we hope this model will be helpful for further exploring the influence and mechanism of iron overload on MDS.

摘要

越来越多的临床证据表明,铁过载可抑制骨髓增生异常综合征患者的造血。然而,铁过载如何影响骨髓增生异常综合征(MDS)中的造血仍不清楚。在此,我们转导了骨髓单核细胞,并与放射保护骨髓细胞一起移植到致死性辐射的受体小鼠中,以生成 MDS 小鼠。移植后 8 周,受体小鼠每隔一天接受一次浓度为 25mg/ml 的 0.2ml 右旋糖酐铁腹腔注射,共 8 次,以建立铁过载模型。在本研究中,我们表明铁过载会损害 MDS 小鼠正常造血干细胞和祖细胞的频率和集落形成能力,特别是在红系中,这至少部分是由于生长分化因子 11 诱导的活性氧,缩短了 MDS 小鼠的存活时间。鉴于我们是第一个在 MDS 小鼠中构建铁过载模型的人,我们希望这个模型将有助于进一步探索铁过载对 MDS 的影响和机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f93/6165791/e9e421382871/1031627.fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f93/6165791/6c6df579b494/1031627.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f93/6165791/2748ecf10b9f/1031627.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f93/6165791/c505b9a7df98/1031627.fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f93/6165791/6ef779e8a5f8/1031627.fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f93/6165791/b89d41d30855/1031627.fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f93/6165791/e9e421382871/1031627.fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f93/6165791/6c6df579b494/1031627.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f93/6165791/2748ecf10b9f/1031627.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f93/6165791/c505b9a7df98/1031627.fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f93/6165791/6ef779e8a5f8/1031627.fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f93/6165791/b89d41d30855/1031627.fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f93/6165791/e9e421382871/1031627.fig6.jpg

相似文献

1
Iron overload impairs normal hematopoietic stem and progenitor cells through reactive oxygen species and shortens survival in myelodysplastic syndrome mice.铁过载通过活性氧物种损害正常造血干/祖细胞,并缩短骨髓增生异常综合征小鼠的存活时间。
Haematologica. 2018 Oct;103(10):1627-1634. doi: 10.3324/haematol.2018.193128. Epub 2018 Jun 14.
2
ROS-mediated iron overload injures the hematopoiesis of bone marrow by damaging hematopoietic stem/progenitor cells in mice.活性氧介导的铁过载通过损伤小鼠造血干/祖细胞来损害骨髓造血。
Sci Rep. 2015 May 13;5:10181. doi: 10.1038/srep10181.
3
Iron overload may promote alteration of NK cells and hematopoietic stem/progenitor cells by JNK and P38 pathway in myelodysplastic syndromes.铁过载可能通过JNK和P38信号通路促进骨髓增生异常综合征中自然杀伤细胞和造血干/祖细胞的改变。
Int J Hematol. 2017 Aug;106(2):248-257. doi: 10.1007/s12185-017-2237-x. Epub 2017 Apr 12.
4
Intracellular ROS profile in hematopoietic progenitors of MDS patients: association with blast count and iron overload.骨髓增生异常综合征患者造血祖细胞内 ROS 谱:与原始细胞计数和铁过载的关系。
Hematology. 2021 Dec;26(1):88-95. doi: 10.1080/16078454.2020.1870373.
5
Reactive oxygen species mediated T lymphocyte abnormalities in an iron-overloaded mouse model and iron-overloaded patients with myelodysplastic syndromes.活性氧介导铁过载小鼠模型及铁过载骨髓增生异常综合征患者的T淋巴细胞异常。
Ann Hematol. 2017 Jul;96(7):1085-1095. doi: 10.1007/s00277-017-2985-y. Epub 2017 Apr 18.
6
[Effects of oxidative stress on hematopoiesis of hematopoietic stem and progenitor cells with iron overload].[氧化应激对铁过载状态下造血干细胞和祖细胞造血作用的影响]
Zhonghua Yi Xue Za Zhi. 2011 Dec 13;91(46):3284-8.
7
Iron overload promotes erythroid apoptosis through regulating HIF-1a/ROS signaling pathway in patients with myelodysplastic syndrome.铁过载通过调节骨髓增生异常综合征患者的HIF-1α/ROS信号通路促进红系凋亡。
Leuk Res. 2017 Jul;58:55-62. doi: 10.1016/j.leukres.2017.04.005. Epub 2017 Apr 23.
8
Quercetin induces autophagy in myelodysplastic bone marrow including hematopoietic stem/progenitor compartment.槲皮素诱导骨髓增生异常包括造血干/祖细胞区室的自噬。
Environ Toxicol. 2021 Feb;36(2):149-167. doi: 10.1002/tox.23020. Epub 2020 Sep 9.
9
Iron overload in myelodysplastic syndromes: Evidence based guidelines from the Canadian consortium on MDS.骨髓增生异常综合征中的铁过载:来自加拿大骨髓增生异常综合征联盟的循证指南
Leuk Res. 2018 Nov;74:21-41. doi: 10.1016/j.leukres.2018.09.005. Epub 2018 Sep 19.
10
Deferasirox reduces oxidative DNA damage in bone marrow cells from myelodysplastic patients and improves their differentiation capacity.地拉罗司可降低骨髓增生异常患者骨髓细胞的氧化 DNA 损伤,并提高其分化能力。
Br J Haematol. 2019 Oct;187(1):93-104. doi: 10.1111/bjh.16013. Epub 2019 Jun 6.

引用本文的文献

1
Fe-doped MOF nanoparticles: the LIFR and BMP4 dual-signaling pathways activated regulator for in vitro expansion of mouse embryonic stem cells.铁掺杂的金属有机框架纳米颗粒:用于小鼠胚胎干细胞体外扩增的LIFR和BMP4双信号通路激活调节剂。
Mater Today Bio. 2025 Jul 7;33:102042. doi: 10.1016/j.mtbio.2025.102042. eCollection 2025 Aug.
2
Clinical features and outcomes of myelodysplastic syndrome patients with iron overload: a single-center retrospective study.铁过载的骨髓增生异常综合征患者的临床特征与转归:一项单中心回顾性研究
Eur J Med Res. 2025 Jul 9;30(1):600. doi: 10.1186/s40001-025-02848-1.
3
Iron chelation therapy in myelodysplastic syndromes and allogeneic hematopoietic cell transplantation, a delicate balance.

本文引用的文献

1
Iron overload promotes mitochondrial fragmentation in mesenchymal stromal cells from myelodysplastic syndrome patients through activation of the AMPK/MFF/Drp1 pathway.铁过载通过激活 AMPK/MFF/Drp1 通路促进骨髓增生异常综合征患者间充质基质细胞的线粒体碎片化。
Cell Death Dis. 2018 May 1;9(5):515. doi: 10.1038/s41419-018-0552-7.
2
Iron overload in lower international prognostic scoring system risk patients with myelodysplastic syndrome receiving red blood cell transfusions: Relation to infections and possible benefit of iron chelation therapy.接受红细胞输血的国际预后评分系统低危骨髓增生异常综合征患者的铁过载:与感染的关系及铁螯合疗法的潜在益处
Leuk Res. 2018 Apr;67:75-81. doi: 10.1016/j.leukres.2018.02.005. Epub 2018 Feb 10.
3
骨髓增生异常综合征中的铁螯合疗法与异基因造血细胞移植:一种微妙的平衡
Blood Rev. 2025 Jun 23:101319. doi: 10.1016/j.blre.2025.101319.
4
Competition of dual clones in MDS-RS is associated with distinct RNA mis-splicing in hematopoietic stem cells.骨髓增生异常综合征伴环形铁粒幼细胞(MDS-RS)中双克隆的竞争与造血干细胞中不同的RNA错配剪接有关。
Blood Neoplasia. 2024 Apr 12;1(2):100011. doi: 10.1016/j.bneo.2024.100011. eCollection 2024 Jun.
5
Deferasirox improved iron homeostasis and hematopoiesis in ovariectomized rats with iron accumulation.地拉罗司改善了铁蓄积的去卵巢大鼠的铁稳态和造血功能。
Sci Rep. 2025 Jan 19;15(1):2449. doi: 10.1038/s41598-025-86333-z.
6
Ironing out the role of ferroptosis in immunity.消除铁死亡在免疫中的作用。
Immunity. 2024 May 14;57(5):941-956. doi: 10.1016/j.immuni.2024.03.019.
7
Role of reactive oxygen species in myelodysplastic syndromes.活性氧在骨髓增生异常综合征中的作用。
Cell Mol Biol Lett. 2024 Apr 14;29(1):53. doi: 10.1186/s11658-024-00570-0.
8
Increased iron uptake by splenic hematopoietic stem cells promotes TET2-dependent erythroid regeneration.脾造血干细胞中铁摄取的增加促进了 TET2 依赖性红细胞再生。
Nat Commun. 2024 Jan 15;15(1):538. doi: 10.1038/s41467-024-44718-0.
9
Transfusion avoidance in myelodysplastic neoplasms.骨髓增生异常肿瘤中的输血回避。
Curr Opin Hematol. 2024 Mar 1;31(2):40-46. doi: 10.1097/MOH.0000000000000794. Epub 2023 Nov 16.
10
Erythroid Differentiation Enhances RNA Mis-Splicing in SF3B1-Mutant Myelodysplastic Syndromes with Ring Sideroblasts.环形铁幼粒细胞性难治性贫血伴 SF3B1 突变的红细胞分化增强 RNA 错剪接。
Cancer Res. 2024 Jan 16;84(2):211-225. doi: 10.1158/0008-5472.CAN-23-3038.
Reactive oxygen species levels control NF-κB activation by low dose deferasirox in erythroid progenitors of low risk myelodysplastic syndromes.活性氧水平通过低剂量地拉罗司控制低危骨髓增生异常综合征红系祖细胞中NF-κB的激活。
Oncotarget. 2017 Nov 6;8(62):105510-105524. doi: 10.18632/oncotarget.22299. eCollection 2017 Dec 1.
4
Iron overload in myelodysplastic syndromes (MDS).骨髓增生异常综合征(MDS)中的铁过载
Int J Hematol. 2018 Jan;107(1):55-63. doi: 10.1007/s12185-017-2367-1. Epub 2017 Nov 25.
5
Impact of chromosome alterations, genetic mutations and clonal hematopoiesis of indeterminate potential (CHIP) on the classification and risk stratification of MDS.染色体改变、基因突变及意义未明的克隆性造血(CHIP)对骨髓增生异常综合征分类及危险分层的影响
Blood Cells Mol Dis. 2018 Mar;69:90-100. doi: 10.1016/j.bcmd.2017.10.001. Epub 2017 Oct 16.
6
Unraveling the mechanisms behind iron overload and ineffective hematopoiesis in myelodysplastic syndromes.解析骨髓增生异常综合征中铁过载及无效造血背后的机制。
Leuk Res. 2017 Nov;62:108-115. doi: 10.1016/j.leukres.2017.10.001. Epub 2017 Oct 5.
7
[MDS: Recent progress in molecular pathogenesis and clinical aspects].[骨髓增生异常综合征:分子发病机制与临床方面的最新进展]
Rinsho Ketsueki. 2017;58(10):1941-1950. doi: 10.11406/rinketsu.58.1941.
8
Increasing the effectiveness of hematopoiesis in myelodysplastic syndromes: erythropoiesis-stimulating agents and transforming growth factor-β superfamily inhibitors.提高骨髓增生异常综合征中造血作用的有效性:促红细胞生成剂和转化生长因子-β超家族抑制剂
Semin Hematol. 2017 Jul;54(3):141-146. doi: 10.1053/j.seminhematol.2017.06.004. Epub 2017 Jul 4.
9
Overcoming barriers to treating iron overload in patients with lower-risk myelodysplastic syndrome.克服低危骨髓增生异常综合征患者铁过载治疗的障碍。
Crit Rev Oncol Hematol. 2017 Sep;117:57-66. doi: 10.1016/j.critrevonc.2017.07.002. Epub 2017 Jul 12.
10
Essential role of FBXL5-mediated cellular iron homeostasis in maintenance of hematopoietic stem cells.FBXL5 介导的细胞内铁稳态对维持造血干细胞的重要作用。
Nat Commun. 2017 Jul 17;8:16114. doi: 10.1038/ncomms16114.